نتائج البحث - "Konrad J. Werhahn"

1

دورية أكاديمية

Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials

المؤلفون: Michael Rademacher, Manuel Toledo, Wim Van Paesschen, Kore K. Liow, Ivan G. Milanov, Maria‐Luise Esch, Nan Wang, Merran MacPherson, William J. Byrnes, Timothy D. C. Minh, Elizabeth Webster, Konrad J. Werhahn

المصدر: Epilepsia Open, Vol 7, Iss 4, Pp 758-770 (2022)

مصطلحات موضوعية: antiepileptic drug, antiseizure medication, dual mechanism of action, focal seizure, synaptic vesicle protein 2, tolerability, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2470-9239

URL الوصول: https://doaj.org/article/f7b64484d7ee4361b1b24f205981fd0f

View record at Wiley

Find this article in full text from ProQuest

Full Text Finder

2

Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials

المؤلفون: Michael, Rademacher, Manuel, Toledo, Wim, Van Paesschen, Kore K, Liow, Ivan G, Milanov, Maria-Luise, Esch, Nan, Wang, Merran, MacPherson, William J, Byrnes, Timothy D C, Minh, Elizabeth, Webster, Konrad J, Werhahn

المساهمون: Institut Català de la Salut, [Rademacher M] Department of Epileptology, University of Bonn Medical Center, Bonn, Germany. [Toledo M] Unitat d’Epilèpsia, Servei de Neurologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Van Paesschen W] Department of Neurology, University Hospitals Leuven, Leuven, Belgium. [Liow KK] Comprehensive Epilepsy Center, Hawaii Pacific Neuroscience, Honolulu, Hawaii, USA. [Milanov IG] Medical University of Sofia, Sofia, Bulgaria. [Esch ML] UCB Pharma, Monheim am Rhein, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Adult, Drug Resistant Epilepsy, fenómenos fisiológicos::fenómenos farmacológicos y toxicológicos::fenómenos farmacológicos::resistencia a medicamentos [FENÓMENOS Y PROCESOS], Clinical Neurology, administración de los servicios de salud::calidad de la atención sanitaria::evaluación de resultados y procesos (atención a la salud)::evaluación del desenlace (asistencia sanitaria)::resultado del tratamiento [ATENCIÓN DE SALUD], Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Epilepsy [DISEASES], Anticonvulsius - Ús terapèutic, antiepileptic drug, Seizures, dual mechanism of action, Physiological Phenomena::Pharmacological and Toxicological Phenomena::Pharmacological Phenomena::Drug Resistance [PHENOMENA AND PROCESSES], Humans, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::fármacos del sistema nervioso central::anticonvulsivantes [COMPUESTOS QUÍMICOS Y DROGAS], antiseizure medication, tolerability, Resistència als medicaments, Science & Technology, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Central Nervous System Agents::Anticonvulsants [CHEMICALS AND DRUGS], Neurosciences, synaptic vesicle protein 2, focal seizure, Epilèpsia - Tractament, Treatment Outcome, Neurology, Avaluació de resultats (Assistència sanitària), enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::epilepsia [ENFERMEDADES], Anticonvulsants, Drug Therapy, Combination, SEIZURES, Epilepsies, Partial, Neurosciences & Neurology, Neurology (clinical), Life Sciences & Biomedicine, Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome [HEALTH CARE]